| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Acalabrutinib |
|---|
| Description | Purity 98%. Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP-196 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of t |
|---|
| Size | 2 mg, 5 mg, 1ml/10mM (In DMSO), 10 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | CAS: 1420477-60-6 |
|---|
| Catalog # | MBS578493 |
|---|
| Price | |
|---|
| Order / More Info | Acalabrutinib from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|